Sex, Chores Improved With HF Drug's Quality of Life Boost

Join our community to access additional content!

CRT Community

$0.00

Register for Meetings

“In The News” & “Cardiovascular Marketplace” Content Access

Listen to Podcasts

Watch On-Demand Content

CardioTube Access

Access to Recorded Live Broadcasts from CRTvirtual Meetings, DMV, & Cath Conference

Access Recorded Interviews

Download PPT Slide Decks

Join Now!
Already have an account? Login Now

CRT Community Premium

~~$650.00 annually~~
$455.00 annually
Code: CRT30
Apply code at Checkout Offer Expires: May 31, 2025

Register for Meetings

“In The News” & “Cardiovascular Marketplace” Content Access

Listen to Podcasts

Watch On-Demand Content

CardioTube Access

Access to Recorded Live Broadcasts from CRTvirtual Meetings, DMV, & Cath Conference

Access Recorded Interviews

Download PPT Slide Decks

Complimentary subscription to electronic version of the CRM Journal

Access to CRT Meeting Registration Discounts

CRT Premium Content, including on-demand videos and presentation downloads

Join Now!
Already have an account? Login Now
News

Sex, Chores Improved With HF Drug's Quality of Life Boost

Posted: 04/05/2018
Author:
Kate Kneisel, Contributing Writer, MedPage Today April 05, 2018
News News Articles 2018

PARADIGM-HF trial analysis drills into specifics of QOL benefit

Sacubitril/valsartan (Entresto) significantly improved heart failure-related limitations affecting many physical and social activities compared with enalapril, a post hoc secondary analysis of the PARADIGM-HF trial showed.
1-3 of 4208 results
1 2 3 4 5 Next »

Behavioral, Clinical Risk Factors Play a Role in Relationship Between CVD Deaths and Social Health Determinants

May 09, 2025 by
Bailey G. Salimes, CRTonline.org

The association between social determinants of health (SDOH) and increased rates of death due to cardiovascular disease (CVD) is mediated by behavioral and clinical risk factors, a new survey study shows.

Calprotectin Plays Mechanistic Role in Development of ASCVD: Population-Based Study

May 07, 2025 by
Bailey G. Salimes, CRTonline.org

Calprotectin may be a biomarker for atherosclerotic cardiovascular disease (ASCVD), a new study shows.

DSE-Detected Ischemia Predicts PCI Efficacy: ORBITA-2 Data

May 07, 2025 by
Nathan Gray, CRTonline.org

The degree of ischemia detected on dobutamine stress echocardiography (DSE) strongly predicts the efficacy of percutaneous coronary intervention (PCI) in patients with stable coronary artery disease (CAD), according to a new analysis from the ORBITA-2 trial.

1-3 of 4208 results
1 2 3 4 5 Next »

Most Viewed Pages

Novel Technique Employing Transcatheter Balloon-Expandable Valves in Pure Aortic Regurgitation: A Proof-of-Concept Study

DMV (Apr 2025) Distal Left Main Bifurcation Stenting Case

Navitor TAV at Low Implant Depths is ‘More Favorable’ than Other SEVs and Higher Depths: Real-World Simulation

Review of the Recent QFR Studies Principles of QFR and Why We Should Use it

Progression and Outcomes of Mild to Moderate Aortic Stenosis | Insights from the Prospective Observational Study

Explore the Site

Stay Connected

CRT Group Foundation is a not for profit corporation dedicated to providing educational services in the field of cardiology through the website, CRTonline.org and the Cardiovascular Research Technologies (CRT) annual symposium. CRT focuses on the advances and changes in the field of cardiovascular medicine. CRT is designed to provide access to the world’s leading clinicians and the latest research in order to improve practice and treatment outcomes for a variety of health care professionals.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details

Join our community to access additional content!

CRT Community

CRT Community Premium

News

Sex, Chores Improved With HF Drug's Quality of Life Boost

PARADIGM-HF trial analysis drills into specifics of QOL benefit

Behavioral, Clinical Risk Factors Play a Role in Relationship Between CVD Deaths and Social Health Determinants

Calprotectin Plays Mechanistic Role in Development of ASCVD: Population-Based Study

DSE-Detected Ischemia Predicts PCI Efficacy: ORBITA-2 Data

Most Viewed Pages

Explore the Site

Stay Connected